| NCT06785454 | A Study to Assess the Efficacy and Safety of Lorundrostat in Participants With Obstructive Sleep Apnea and Hypertension | RECRUITING | PHASE2 | 2025-02-28 | 2026-01 | 2025-10 |
| NCT06150924 | Efficacy and Safety of Lorundrostat in Addition to Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2i) in Subjects With Hypertension and Chronic Kidney Disease (CKD) With Albuminuria | COMPLETED | PHASE2 | 2023-12-14 | 2025-04-23 | 2025-02-27 |
| NCT06153693 | Efficacy and Safety of Lorundrostat in Subjects With Uncontrolled and Resistant Hypertension | COMPLETED | PHASE3 | 2023-11-22 | 2025-01-24 | 2024-12-10 |
| NCT05968430 | Open-Label Extension (OLE) Study to Assess Safety, Efficacy, and Tolerability of Lorundrostat in Subjects With Hypertension | ACTIVE_NOT_RECRUITING | PHASE3 | 2023-07-14 | 2026-12 | 2025-12 |
| NCT05769608 | A Pivotal Study to Evaluate the Efficacy of Lorundrostat in Subjects With Uncontrolled Hypertension on a Standardized Antihypertensive Medication Regimen | COMPLETED | PHASE2 | 2023-03-13 | 2025-01-15 | 2025-01-15 |
| NCT05001945 | Trial on the Safety and Efficacy of MLS-101 in Patients With Uncontrolled Hypertension | COMPLETED | PHASE2 | 2021-07-01 | 2022-10-07 | 2022-09-07 |